scholarly article | Q13442814 |
P2093 | author name string | T. A. Sears | |
H. Bostock | |||
R. M. Sherratt | |||
P2860 | cites work | The Selective Inhibition of Delayed Potassium Currents in Nerve by Tetraethylammonium Ion | Q24656039 |
ANOMALOUS RECTIFICATION IN THE SQUID GIANT AXON INJECTED WITH TETRAETHYLAMMONIUM CHLORIDE. | Q36405251 | ||
Effects of 4-aminopyridine in myasthenia gravis | Q36991663 | ||
Altered thermal sensitivity in injured and demyelinated nerve: A possible model of temperature effects in multiple sclerosis | Q37079624 | ||
Restoration of transmitter release in botulinum-poisoned skeletal muscle | Q39096671 | ||
Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome | Q39323815 | ||
Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents | Q39381800 | ||
Pathophysiology of demyelinating disease | Q39616712 | ||
Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine | Q40074080 | ||
Effects of 4-aminopyridine on transmission in excitatory and inhibitory synapses in the spinal cord | Q40110727 | ||
Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials | Q40161612 | ||
Negative surface charge near sodium channels of nerve: divalent ions, monovalent ions, and pH | Q40328586 | ||
A quantitative description of membrane currents in rabbit myelinated nerve | Q40723941 | ||
The effect of internal and external 4-aminopyridine on the potassium currents in intracellularly perfused squid giant axons | Q41054347 | ||
Interactions of aminopyridines with potassium channels of squid axon membranes | Q41484282 | ||
Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres | Q41642652 | ||
The effect of tetraethylammonium chloride on single Ranvier's nodes | Q45079920 | ||
Irreverisble differential block of A- and C-fibres following local nerve heating in the cat. | Q51878331 | ||
Potential clamp analysis of membrane currents in rat myelinated nerve fibres. | Q51878333 | ||
Effects of manganese and other agents on the calcium uptake that follows depolarization of squid axons | Q52729616 | ||
Topical application of saxitoxin and tetrodotoxin to peripheral nerves and spinal roots in cat | Q52752630 | ||
Differential nerve block by sodium free and sodium-deficient solutions. | Q52766561 | ||
Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres | Q59090806 | ||
The pathophysiology of demyelination and its implications for the symptomatic treatment of multiple sclerosis | Q67016913 | ||
The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination | Q67379534 | ||
Proceedings: Selective inhibition of potassium current in the giant axon of the cockroach | Q68887296 | ||
A computer simulation of conduction in demyelinated nerve fibres | Q69455642 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | physiology | Q521 |
P304 | page(s) | 301-315 | |
P577 | publication date | 1981-01-01 | |
P1433 | published in | Journal of Physiology | Q7743612 |
P1476 | title | The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres | |
The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres | |||
P478 | volume | 313 |
Q43181143 | 4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis |
Q71663753 | 4-Aminopyridine and fiber potentials in rat and human hippocampal slices |
Q27007478 | 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review |
Q37514791 | 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury |
Q47939982 | A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions |
Q52423165 | A distributed-parameter model of the myelinated nerve fiber. |
Q90215929 | A surprising role for myelin in Williams syndrome |
Q41729745 | Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injury |
Q67508351 | Action potential refractory period in axonal demyelination: a computer simulation |
Q46593434 | Actions of potassium channel blockers on guinea-pig lateral olfactory tract axons |
Q35648729 | Age-related molecular reorganization at the node of Ranvier |
Q50856877 | Alterations of juxtaparanodal domains in two rodent models of CNS demyelination. |
Q48580172 | Aminopyridine-sensitivity of spinal cord white matter studied in vitro |
Q39153784 | Aminopyridines for the treatment of neurologic disorders |
Q48414814 | Astrocytes selectively enhance N-type calcium current in hippocampal neurons |
Q34080477 | Axonal flip-flops and oscillators |
Q72998016 | Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction |
Q40088766 | Cellular neurophysiological effects of phenol derivatives |
Q90732168 | Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells |
Q35587123 | Central action of dendrotoxin: selective reduction of a transient K conductance in hippocampus and binding to localized acceptors |
Q42588431 | Central motor conduction time may predict response to fampridine in patients with multiple sclerosis |
Q70317578 | Conduction block in the peripheral nervous system in experimental allergic encephalomyelitis |
Q73692426 | Conduction in segmentally demyelinated mammalian central axons |
Q72799005 | Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders |
Q36873901 | Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis |
Q47866552 | Development of a PET radioligand for potassium channels to image CNS demyelination. |
Q74210742 | Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord |
Q68991172 | Differential sensitivity of amphibian nodal and paranodal K+ channels to 4-aminopyridine and TEA |
Q28539451 | Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination |
Q47934172 | Ectopic activity in demyelinated spinal root axons of the rat |
Q47744425 | Effect of 4-Aminopyridine on Genioglossus Muscle Activity during Sleep in Healthy Adults |
Q73340717 | Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease |
Q42134216 | Effects of pyrethroid molecules on rat nerves in vitro: potential to reverse temperature-sensitive conduction block of demyelinated peripheral axons |
Q51840965 | Electrical activity of mouse motor nerve terminals |
Q40638938 | Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury. |
Q48951458 | Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat |
Q72927000 | Evidence for the presence of potassium channels in the internode of frog myelinated nerve fibres |
Q35888496 | Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve |
Q69805775 | Features of 4-aminopyridine sensitive outward current observed in single smooth muscle cells from the rabbit pulmonary artery |
Q53916881 | Frequency dependent intermittency and ionic basis of impulse conduction in postganglionic sympathetic fibres of guinea-pig vas deferens |
Q51795801 | Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. |
Q34956446 | Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis |
Q39865756 | In vitro and intrathecal siRNA mediated K(V)1.1 knock-down in primary sensory neurons |
Q48159462 | Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel |
Q35701106 | Information processing in the axon |
Q36565854 | Ion channel organization of the myelinated fiber |
Q52168360 | Ion channel sequestration in central nervous system axons. |
Q33960965 | K(+) channels as therapeutic drug targets |
Q45066349 | K+ channel blockade impairs remyelination in the cuprizone model |
Q36907606 | KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: support for electrically active myelin in mammalian saltatory conduction. |
Q43585277 | Lidocaine selectively blocks abnormal impulses arising from noninactivating Na channels |
Q70154928 | Long-term regenerated nerve fibres retain sensitivity to potassium channel blocking agents |
Q59064266 | Loosening of paranodal myelin by repetitive propagation of action potentials |
Q80422826 | Mechanisms of hyperpolarization in regenerated mature motor axons in cat |
Q34305770 | Molecular dissection of the myelinated axon |
Q36942808 | Molecular mechanisms of inherited demyelinating neuropathies |
Q37020112 | Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. |
Q37020056 | Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons |
Q70019157 | Multiple sclerosis: failure of treatment with verapamil in a pilot trial |
Q69003807 | Na currents and action potentials in rat myelinated nerve fibres at 20 and 37 degrees C |
Q37074091 | No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse |
Q40166401 | Ontogenesis of the Axolemma and Axoglial Relationships in Myelinated Fibers: Electrophysiological and Freeze-Fracture Correlates of Membrane Plasticity |
Q34258996 | Optical recording of action potential propagation in demyelinated frog nerve |
Q38730482 | Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis. |
Q43282334 | Oxidative stress and the muscle reflex in heart failure. |
Q91710141 | Paroxysmal Discharges in Tissue Slices From Pediatric Epilepsy Surgery Patients: Critical Role of GABAB Receptors in the Generation of Ictal Activity |
Q40080549 | Pathophysiology of Demyelination |
Q44424378 | Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury |
Q51770011 | Physiological and morphological changes in developing peripheral nerves of rat embryos |
Q51727662 | Potassium channel blockade differentially affects the relative refractory period of frog afferent terminals and axons. |
Q37832653 | Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons |
Q70159507 | Potassium channel distribution in spinal root axons of dystrophic mice |
Q73977270 | Potassium channel distribution, clustering, and function in remyelinating rat axons |
Q70171596 | Potassium channels moderate ectopic excitability of nerve-end neuromas in rats |
Q40137475 | Potassium currents in the frog node of Ranvier |
Q70714685 | Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury |
Q51849825 | Presynaptic currents in frog motor endings |
Q67296492 | Presynaptic currents in mouse motor endings |
Q72917672 | Presynaptic effects of 4-aminopyridine and streptomycin on the neuromuscular junction |
Q72547247 | Regenerating mammalian nerve fibres: changes in action potential waveform and firing characteristics following blockage of potassium conductance |
Q39420410 | Remyelination therapies: a new direction and challenge in multiple sclerosis |
Q41405823 | Restoration of Visual Function by Enhancing Conduction in Regenerated Axons |
Q89542998 | Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond |
Q35012930 | Sensory afferents regenerated into dorsal columns after spinal cord injury remain in a chronic pathophysiological state |
Q50668577 | Short- and long-term functional plasticity of white matter induced by oligodendrocyte depolarization in the hippocampus. |
Q36142039 | Single-pixel optical fluctuation analysis of calcium channel function in active zones of motor nerve terminals |
Q43526252 | Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat |
Q92527444 | Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers |
Q34316615 | The PMP22 gene and its related diseases |
Q51377428 | The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. |
Q42706140 | The effects of anticonvulsants on 4-aminopyridine-induced bursting: in vitro studies on rat peripheral nerve and dorsal roots |
Q98164513 | The effects of temperature on the biophysical properties of optic nerve F-fibres |
Q52729187 | The induction of periodic and chaotic activity in a molluscan neurone. |
Q24676476 | The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease |
Q48657458 | The rat gracile nucleus in vitro: I. Evidence for a GABA-mediated depolarisation of the dorsal column afferents |
Q35981034 | The use of 4-aminopyridine (fampridine) in demyelinating disorders. |
Q48422530 | Thiamine and its derivatives inhibit delayed rectifier potassium channels of rat cultured cortical neurons |
Q82792290 | Threshold behaviour of human axons explored using subthreshold perturbations to membrane potential |
Q69963006 | Toxic effects of triethyldodecylammoniumbromide (TEA-C12) on myelinated nerve fibers and blood-nerve barrier in the mouse |
Q35018452 | Treatment of walking impairment in multiple sclerosis with dalfampridine |
Q72578520 | Two types of 4-aminopyridine-sensitive potassium current in rabbit Schwann cells |
Q71059925 | Upregulation of GABAA current by astrocytes in cultured embryonic rat hippocampal neurons |
Q96693384 | White matter alterations in Williams syndrome related to behavioral and motor impairments |
Q52559078 | [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers] |
Search more.